[Prevention of postoperative thromboembolic complications among patients with prostatic adenoma].
M D
MD
Dzhabad-Zade
S N
SN
Lynev
K N
KN
Gadzhimuradov
D000925:Anticoagulants / Q000627:therapeutic use; D002395:Catecholamines / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000517:prevention & control; D004598:Electrosurgery; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care; D011470:Prostatic Hyperplasia / Q000601:surgery*; D011655:Pulmonary Embolism / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control
D000925:Anticoagulants; D002395:Catecholamines; D003911:Dextrans; D005938:Glucocorticoids; D006493:Heparin
Profilaktika posleoperatsionnykh tromboĕmbolicheskikh oslozhneniĭ u bol'nykh adenomoĭ predstatel'noĭ zhelezy.